Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Canton Strategic Holdings, Inc. (CNTN : NSDQ)

• Company Description    Tharimmune Inc. is a biotechnology company. It involved in developing a portfolio of therapeutic candidates for rare immune, inflammatory and oncologic diseases. Tharimmune Inc., formerly known as Hillstream BioPharma Inc., is based in BRIDGEWATER, NJ. Number of Employees: 12

• Price / Volume Information    Yesterday's Closing Price: $1.94 Daily Weekly Monthly 20 Day Moving Average: 937,638 shares Shares Outstanding: 77.12 (millions) Market Capitalization: $149.62 (millions) Beta: 1.42 52 Week High: $9.08 52 Week Low: $1.08 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -27.75% -28.28% 12 Week -39.94% -41.58% Year To Date -35.97% -37.18%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 34 Shrewsbury Avenue Suite 1C - Red Bank,NJ 07701 USA ph: 732-889-3111 fax: - ir@cantonstrategic.com http://www.cantonstrategic.com

• General Corporate Information    Officers Mark Wendland - Chief Executive Officer and Chairman Mark Toomey - President Angela Dominy Radkowski - Chief Operating Officer Jacob Asbury - Chief Financial Officer Jill Sommers - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: FIN-MISC SVCS Sector: Finance CUSIP: 432705309 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/13/26 Share - Related Items Shares Outstanding: 77.12 Most Recent Split Date: 5.00 (0.07:1) Beta: 1.42 Market Capitalization: $149.62 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/13/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.23 Price/Cash Flow: - Price / Sales: - EPS Growth vs. Year Ago Period: 82.83% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 06/30/26 - - 03/31/26 - -31.50 12/31/25 - -35.59 ROA 06/30/26 - - 03/31/26 - -24.72 12/31/25 - -27.05 Current Ratio 06/30/26 - - 03/31/26 - 37.76 12/31/25 - 5.29 Quick Ratio 06/30/26 - - 03/31/26 - 37.76 12/31/25 - 5.29 Operating Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Net Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Pre-Tax Margin 06/30/26 - - 03/31/26 - - 12/31/25 - - Book Value 06/30/26 - - 03/31/26 - 8.29 12/31/25 - 10.92 Inventory Turnover 06/30/26 - - 03/31/26 - - 12/31/25 - - Debt-to-Equity 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00 Debt-to-Capital 06/30/26 - - 03/31/26 - 0.00 12/31/25 - 0.00

Powered by Zacks Investment Research ©